Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.

Published on Apr 5, 2020in Acta neuropathologica communications6.27
· DOI :10.1186/S40478-020-00916-7
Yuji Matsumoto6
Estimated H-index: 6
(Okayama University),
Tomotsugu Ichikawa22
Estimated H-index: 22
(Okayama University)
+ 10 AuthorsIsao Date58
Estimated H-index: 58
(Okayama University)
Sources
Abstract
Glioblastoma (GBM) is characterized by extensive tumor cell invasion, angiogenesis, and proliferation. We previously established subclones of GBM cells with distinct invasive phenotypes and identified annexin A2 (ANXA2) as an activator of angiogenesis and perivascular invasion. Here, we further explored the role of ANXA2 in regulating phenotypic transition in GBM. We identified oncostatin M receptor (OSMR) as a key ANXA2 target gene in GBM utilizing microarray analysis and hierarchical clustering analysis of the Ivy Glioblastoma Atlas Project and The Cancer Genome Atlas datasets. Overexpression of ANXA2 in GBM cells increased the expression of OSMR and phosphorylated signal transducer and activator of transcription 3 (STAT3) and enhanced cell invasion, angiogenesis, proliferation, and mesenchymal transition. Silencing of OSMR reversed the ANXA2-induced phenotype, and STAT3 knockdown reduced OSMR protein expression. Exposure of GBM cells to hypoxic conditions activated the ANXA2-STAT3-OSMR signaling axis. Mice bearing ANXA2-overexpressing GBM exhibited shorter survival times compared with control tumor-bearing mice, whereas OSMR knockdown increased the survival time and diminished ANXA2-mediated tumor invasion, angiogenesis, and growth. Further, we uncovered a significant relationship between ANXA2 and OSMR expression in clinical GBM specimens, and demonstrated their correlation with tumor histopathology and patient prognosis. Our results indicate that the ANXA2-STAT3-OSMR axis regulates malignant phenotypic changes and mesenchymal transition in GBM, suggesting that this axis is a promising therapeutic target to treat GBM aggressiveness.
📖 Papers frequently viewed together
5 Citations
8 Authors (Renjie Wang, ..., Haiqian Liang)
121 Citations
1 Citations
References45
Newest
#1Yusuke Tomita (Okayama University)H-Index: 6
#2Kazuhiko Kurozumi (Okayama University)H-Index: 23
Last. Isao Date (Okayama University)H-Index: 58
view all 13 authors...
Anti-vascular endothelial growth factor treatments such as bevacizumab have demonstrated convincing therapeutic advantage in glioblastoma patients. However, bevacizumab has also been reported to induce invasiveness of glioma. In this study, we examined the effects of Rapid Antiangiogenesis Mediated By Oncolytic virus (RAMBO), an oncolytic herpes simplex virus-1 expressing vasculostatin, on bevacizumab-induced glioma invasion. The effect of the combination of RAMBO and bevacizumab in vitro was as...
10 CitationsSource
#1Yoshihiro Otani (University of Texas Health Science Center at Houston)H-Index: 7
#2Tomotsugu IchikawaH-Index: 22
Last. Isao Date (Okayama University)H-Index: 58
view all 4 authors...
Gliomas are characterized as highly diffuse infiltrating tumors, and currently available treatments such as surgery, radiation and chemotherapy are unfeasible or show limited efficacy against these tumors. Recent genetic and epigenetic analyses of glioma have revealed increasing evidence of the role of driver genetic alterations in glioma development and led to the identification of prognostic factors. Despite these findings, the survival rates of glioma patients remain low, and alternative trea...
1 CitationsSource
#1Ralph B. Puchalski (Allen Institute for Brain Science)H-Index: 6
#2Nameeta ShahH-Index: 12
Last. Greg FoltzH-Index: 11
view all 80 authors...
Glioblastoma is an aggressive brain tumor that carries a poor prognosis. The tumor’s molecular and cellular landscapes are complex, and their relationships to histologic features routinely used for diagnosis are unclear. We present the Ivy Glioblastoma Atlas, an anatomically based transcriptional atlas of human glioblastoma that aligns individual histologic features with genomic alterations and gene expression patterns, thus assigning molecular information to the most important morphologic hallm...
176 CitationsSource
#1Yoshihiro Otani (Okayama University)H-Index: 7
#2Tomotsugu Ichikawa (Okayama University)H-Index: 22
Last. Isao Date (Okayama University)H-Index: 58
view all 13 authors...
Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion
15 CitationsSource
#1Justyna A Kucia-Tran (University of Cambridge)H-Index: 2
#2Valtteri Tulkki (University of Cambridge)H-Index: 2
Last. Nicholas Coleman (University of Cambridge)H-Index: 65
view all 12 authors...
: The oncostatin M (OSM) receptor (OSMR) shows frequent gene copy number gains and overexpression in cervical squamous cell carcinomas (SCCs), associated with adverse clinical outcomes. In SCC cells that overexpress OSMR, the major ligand OSM induces multiple pro-malignant effects, including invasion, secretion of angiogenic factors, and metastasis. Here, we demonstrate, for the first time, that OSMR overexpression in SCC cells activates cell-autonomous feed-forward signalling, via further expre...
11 CitationsSource
#1Qianghu WangH-Index: 23
#2Baoli HuH-Index: 16
Last. Roel G.W. VerhaakH-Index: 55
view all 34 authors...
71 CitationsSource
#1Maria V. Christensen (UCPH: University of Copenhagen)H-Index: 2
#2Claus Høgdall (UCPH: University of Copenhagen)H-Index: 61
Last. Estrid Høgdall (UCPH: University of Copenhagen)H-Index: 59
view all 4 authors...
Annexin A2 is a 36-kDa protein interfering with multiple cellular processes especially in cancer progression. The present review aimed to show the relations between Annexin A2 and cancer. A systematic search for studies investigating cancer and Annexin A2 expression was conducted using PubMed. Acute lymphoblastic leukaemia, acute promyelocytic leukaemia, clear cell renal cell carcinoma, breast, cervical, colorectal, endometrial, gastric cancer, glioblastoma, hepatocellular carcinoma, lung, multi...
60 CitationsSource
#1Act Iv trial investigators (UZH: University of Zurich)H-Index: 1
Summary Background Rindopepimut (also known as CDX-110), a vaccine targeting the EGFR deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet haemocyanin. In the ACT IV study, we aimed to assess whether or not the addition of rindopepimut to standard chemotherapy is able to improve survival in patients with EGFRvIII-positive glioblastoma. Methods In this randomised, double-blind, phase 3 trial, we recruited patients aged 18 years and older with glioblast...
400 CitationsSource
#1Kazuhiko Shien (University of Texas MD Anderson Cancer Center)H-Index: 19
#2Vassiliki A. Papadimitrakopoulou (University of Texas MD Anderson Cancer Center)H-Index: 67
Last. Julie G. Izzo (University of Texas MD Anderson Cancer Center)H-Index: 30
view all 17 authors...
Molecularly targeted drugs have yielded significant therapeutic advances in oncogene-driven non–small cell lung cancer (NSCLC), but a majority of patients eventually develop acquired resistance. Recently, the relation between proinflammatory cytokine IL6 and resistance to targeted drugs has been reported. We investigated the functional contribution of IL6 and the other members of IL6 family proinflammatory cytokine pathway to resistance to targeted drugs in NSCLC cells. In addition, we examined ...
28 CitationsSource
#1Qisheng Tang (Fudan University)H-Index: 3
#2Yuxi Lian (Fudan University)H-Index: 3
Last. Chen Liang (Fudan University)
view all 6 authors...
Background Tumor location served as an important prognostic factor in glioma patients was considered to postulate molecular features according to cell origin theory. However, anatomic distribution of unique molecular subtypes was not widely investigated. The relationship between molecular phenotype and histological subgroup were also vague based on tumor location. Our group focuses on the study of glioma anatomic location of distinctive molecular subgroups and histology subtypes, and explores th...
13 CitationsSource
Cited By4
Newest
#1Thomas Grewal (USYD: University of Sydney)H-Index: 40
#2Carles Rentero (University of Barcelona)H-Index: 28
Last. Ursula Rescher (WWU: University of Münster)H-Index: 30
view all 6 authors...
Routine manipulation of the mouse genome has become a landmark in biomedical research. Traits that are only associated with advanced developmental stages can now be investigated within a living organism, and the in vivo analysis of corresponding phenotypes and functions advances the translation into the clinical setting. The annexins, a family of closely related calcium (Ca2+)- and lipid-binding proteins, are found at various intra- and extracellular locations, and interact with a broad range of...
3 CitationsSource
#1Xin Li (CSU: Central South University)H-Index: 6
#1Xin Li (CSU: Central South University)H-Index: 4
Last. Shan Wang (CSU: Central South University)H-Index: 10
view all 13 authors...
In order to set up a reliable prediction system for the tumor grade and prognosis in glioma patients, we clarify the complicated crosstalk of Annexin A2 (ANXA2) with Glypican 1 (GPC1) and demonstrate whether combined indexes of ANXA2 and GPC1 could improve the prognostic evaluation for glioma patients. We found that ANXA2-induced glioma cell proliferation in a c-Myc-dependent manner. ANXA2 increased the expression of GPC1 via c-Myc and the upregulated GPC1 further promoted the c-Myc level, formi...
2 CitationsSource
#1Bo Pang (HMU: Harbin Medical University)H-Index: 11
#2Fei Quan (HMU: Harbin Medical University)H-Index: 4
Last. Lin Pang (HMU: Harbin Medical University)H-Index: 8
view all 6 authors...
Glioblastoma (GBM) is characterized by rapid and lethal infiltration of brain tissue, which is the primary cause of treatment failure and deaths for GBM. Therefore, understanding the molecular mechanisms of tumor cell invasion is crucial for the treatment of GBM. In this study, we dissected the single-cell RNA-seq data of 3345 cells from four patients and identified dysregulated genes including long non-coding RNAs (lncRNAs), which were involved in the development and progression of GBM. Based o...
Source
#1Milad Ashrafizadeh (University of Tabriz)H-Index: 18
#2Ali Zarrabi (Sabancı University)H-Index: 20
Last. Reza Mohammadinejad (KMU: Kerman Medical University)H-Index: 23
view all 12 authors...
Molecular signaling pathways play a significant role in the regulation of biological mechanisms, and their abnormal expression can provide the conditions for cancer development. The signal transducer and activator of transcription 3 (STAT3) is a key member of the STAT proteins and its oncogene role in cancer has been shown. STAT3 is able to promote the proliferation and invasion of cancer cells and induces chemoresistance. Different downstream targets of STAT3 have been identified in cancer and ...
14 CitationsSource